Phase 1,Randomized,Open-Label,Two Period Single Dose Crossover Bioequivalence Study of Two Capsule Strengths of SPD544 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2011
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Shire Pharmaceutical Development
- 27 Jul 2011 Actual initiation date (Aug 2010) and primary endpoint added as reported by ClinicalTrials.gov.
- 26 Nov 2010 Status changed from not yet recruiting to completed.
- 03 Sep 2010 New trial record